2025 年 7 月 28 日，公司已完成上述事项的工商变更登记手续，并取得由德 州市行政审批服务局换发的最新《营业执照》。 换发的最新《营业执照》证载信息如下： 统一社会信用代码：91371400723870085E 名 称：保龄宝生物股份有限公司 类 型：股份有限公司(上市) 股票代码：002286 股票简称：保龄宝 公告编号：2025-045 保龄宝生物股份有限公司 关于完成经营范围工商变更登记的公告 公司董事会及全体成员保证公告内容真实、准确和完整，不存在虚假记录、 误导性陈述或者重大遗漏。 保龄宝生物股份有限公司（以下简称"公司"）分别于 2025 年 6 月 9 日召 开第六届董事会第十一次会议及 2025 年 6 月 26 日召开 2025 年第二次临时股东 会审议通过了《关于变更公司经营范围及修订<公司章程>的议案》。具体内容 详见公司于 2025 年 6 月 10 日在指定信息披露媒体披露的《关于变更公司经营范 围及修订<公司章程>的公告》（公告编号：2025-039）和 2025 年 6 月 27 日披露 的《2025 年第二次临时股东会决议公告》（公告编号：2025-044）。 住 所： ...

Group 1 - A total of 12 stocks received buy ratings from institutions today, with Baolingbao, Puluo Pharmaceutical, and Xinyuanwei being newly covered by institutions [1] - Among the stocks rated, the average increase was 1.14%, outperforming the Shanghai Composite Index, with notable gainers including Xinyuanwei, Shantui, and Hanyi, which rose by 5.56%, 4.41%, and 4.09% respectively [1] - The stocks with the largest declines included Jinbo Biological, Baofeng Energy, and Miao Exhibition, which fell by 2.14%, 1.70%, and 1.60% respectively [1] Group 2 - The newly rated stocks include Puluo Pharmaceutical with a strong buy rating from Huachuang Securities, and Baolingbao with an increase rating from Guotai Haitong [2] - The target price for Puluo Pharmaceutical is set at 22.00 yuan, while Baolingbao has a target price of 16.30 yuan [2] - Other stocks receiving buy ratings include Miaokelan Duo, Tielong Logistics, and Gole Technology, with target prices of 33.00 yuan, 7.09 yuan, and unspecified respectively [2]

Group 1: Company Insights - The company Honghua Digital Science has announced a forecast for its 2025 half-year report, expecting revenue between 1.02 billion to 1.06 billion yuan, representing a year-on-year increase of 25.01% to 29.91% [3] - The net profit attributable to shareholders is projected to be between 240 million to 260 million yuan, reflecting a year-on-year growth of 19.90% to 29.89% [3] - The company benefits from the accelerated transition from traditional printing to digital printing, leading to sustained order growth and expansion of domestic and international customer bases [1][3] Group 2: Industry Trends - The digital printing equipment sector is experiencing rapid growth, with a projected revenue increase of 114.66% year-on-year for 2024, driven by technological advancements and channel expansion [3] - The textile and printing industry is undergoing a transformation, with digital printing becoming essential for responding to fast fashion demands and reducing processing costs [3] - The construction materials industry in Xinjiang is benefiting from geographical advantages, with cement prices maintaining better stability than the national average, supported by the commencement of the China-Kyrgyzstan-Uzbekistan railway [1][14][41] Group 3: Market Strategy - In Q2 2025, active funds increased their stock positions, particularly in the communication, banking, military, and non-bank sectors, while reducing exposure to food and beverage, automotive, and electric sectors [2][6] - The IPO market is showing signs of recovery, with a significant increase in the number of accepted applications and first-day gains remaining above 220% [9][11] - The construction of the China-Kyrgyzstan-Uzbekistan railway is expected to generate a cement demand of approximately 400-600 million tons, benefiting local cement producers [40][41]

Core Insights - The crystallized fructose industry in China has experienced rapid growth, with the market size projected to increase from 103 million yuan in 2019 to 196 million yuan in 2024, driven by its low glycemic index and suitability for sugar-sensitive populations [1][14]. Industry Overview - Crystallized fructose is a monosaccharide, an isomer of glucose, with a sweetness level 1.2 to 1.8 times that of sucrose. It is naturally found in fruits, honey, and the juices of grains, and is characterized by low caloric value and quick metabolism in the body [3]. - The main product types in the market include crystallized fructose powder and liquid crystallized fructose, with the powder being the primary form [4]. Industry Chain - The upstream raw materials for crystallized fructose production include corn and sugarcane, with corn being a significant source through starch sugar pathways. The industry chain encompasses production, processing, and application in sectors such as food, beverages, pharmaceuticals, and health products [6]. Market Demand - The food and beverage industry is the primary application area for crystallized fructose, used in various products like carbonated drinks, fruit juices, and energy drinks. The market for the food and beverage industry in China is expected to reach 12.14 trillion yuan in 2024, reflecting a 3.61% year-on-year increase [10]. Competitive Landscape - The crystallized fructose market is competitive, with leading companies leveraging brand influence and production scale. Emerging firms are expanding their market share through technological innovation and differentiated products. Key players include Baolingbao Biological, Shandong Bailong Chuangyuan, and Anhui Hongchang Sugar Industry Technology [16][19]. Industry Trends - The precision control of particle size in crystallized fructose production is expected to improve, enhancing product diversity and market adaptability [21]. - The application of crystallized fructose is anticipated to expand beyond traditional food and beverage sectors into pharmaceuticals and health products, with potential uses in specialized foods and pet nutrition [22]. - Continuous technological advancements are necessary to improve production efficiency and product quality, addressing the industry's growing demand [23].

Core Viewpoint - The corn industry is a strategic pillar for China's food security, with significant growth in planting area, yield, and total production expected in 2024, despite short-term market adjustments due to international price fluctuations and rising costs [1][8][14]. Group 1: Industry Overview - The corn processing industry in China has developed a complete industrial chain, from primary processing to modern biobased material research, becoming a key hub for agricultural production and industrial manufacturing [1][5][14]. - Corn processing can be categorized into primary processing and deep processing, producing various products for food, feed, and industrial applications [2][3][5]. Group 2: Current Development Status - In 2024, China's corn planting area is projected to reach 44.74 million hectares, a year-on-year increase of 1.18%, with a yield of 439.4 kg/mu, contributing to a total production of 294.92 million tons, a 2.1% increase from the previous year [1][8][10]. - The total corn consumption in 2024 is expected to reach 31.78 million tons, with industrial consumption growing by 3.07% to 7.94 million tons, driven by innovations in deep processing [12][14]. Group 3: Market Trends - The corn deep processing market size is expected to adjust to 190 billion yuan in 2024, down 6.4% from its peak in 2022, but the long-term growth trend remains solid [1][14]. - The corn processing industry is transitioning towards green and low-carbon practices, focusing on high-value product development such as polylactic acid and functional sugars [24][25][26]. Group 4: Competitive Landscape - The corn deep processing industry in China has a tiered competitive structure, with leading companies like COFCO Technology and Meihua Biological occupying the top tier, focusing on high-value products [20][22]. - The market for corn starch is highly concentrated, with top companies holding over 44% market share, and there is a trend towards differentiation and expansion into biobased materials and other emerging fields [22][24].

Core Viewpoint - The company Baolingbao (002286) is currently facing challenges in the market, with its stock price at 12.55 yuan, down 2.03%, and significant trading activity noted on July 3, 2025 [1] Group 1: Company Developments - The company clarified that its DHA algal oil production does not strictly fall under the definition of marine economy as outlined in the national marine economic development plan [1] - Baolingbao's product, Alotose, has not yet been approved for sale in the domestic market, and the approval timeline for its enzyme preparation remains uncertain [1] - The company has submitted an application for the domestic approval of its Alotose enzyme preparation, but it is still pending [1] Group 2: Market Activity - On July 3, 2025, the net outflow of main funds from Baolingbao was 102 million yuan, while speculative funds saw a net inflow of 26.07 million yuan, and retail investors contributed a net inflow of 75.65 million yuan [1]

Industry Overview - The approval of D-alloheptulose as a new food ingredient aligns with the trend of innovation and upgrading in China's sugar substitute industry, indicating a potential for rapid market penetration in beverages, baking, and confectionery sectors [1][3] - The global market for D-alloheptulose is projected to reach $147.7 million by 2024, with the U.S. market accounting for 30% and an expected compound annual growth rate (CAGR) exceeding 14% from 2025 to 2034 [1] Company Developments - Baolingbao has been involved in the research and development of D-alloheptulose for nearly 10 years and plans to complete a technical transformation project in 2024 with an annual production capacity exceeding 5,000 tons [2] - Shandong Sanyuan Biotechnology has an existing annual production capacity of 10,000 tons of D-alloheptulose and is expanding with a second production line of the same capacity [2] - Jinhe Industrial has an annual production capacity of 1,000 tons of D-alloheptulose, while Shandong Bailong Chuangyuan has recently commenced production of its D-alloheptulose products [2]

Summary of Key Points from the Conference Call Industry Overview - The approval of allulose as a new food ingredient expands its application in the food sector, particularly in weight loss and diabetes-related products, and allows for food thermal processing, although production methods have specific strain and donor limitations [1][4][16]. Company Insights COFCO Technology - COFCO Technology has developed allulose production technology using corn starch and has received approval for related enzyme preparations, advancing the construction of a production line with a capacity of 10,000 tons. Expected net profits for 2025-2027 are projected at 100 million, 160 million, and 230 million yuan respectively, with a year-on-year growth rate of approximately 300% this year [1][5]. Bailingbao - Bailingbao is a leading company in functional metabolic products, with a production capacity exceeding 5,000 tons and plans to expand to 30,000 tons by 2026. The company is primarily focused on exports [1][7]. Bailing Chuangyuan - Bailing Chuangyuan is the first company in China to achieve industrial-scale production and revenue from allulose, with a projected revenue of 156 million yuan in 2024 and a gross margin of 19%. The company plans to expand capacity in Thailand, primarily for export [1][6][17]. Jinhui Industrial - Jinhui Industrial is a leader in the sugar substitute industry, with a leading global market share in sucralose and acesulfame. The company is actively developing allulose and offers blended sweetness solutions [3][13]. Jindawei - Jindawei is constructing a 30,000-ton allulose project, benefiting from the approval of allulose as a food additive. The company has also acquired the US brand RX Sugar to expand its portfolio [22]. Market Dynamics - Allulose is viewed as a potential substitute for sucrose, with a sweetness level of 70% compared to sucrose but only 1/10th the calories. It has health benefits such as vascular softening and blood sugar regulation, making it suitable for weight loss and diabetes applications [2][16]. - The global sugar substitute market is still in its early stages, with only about 10% of global food consumption utilizing sugar substitutes. The market for sugar substitutes is expected to grow significantly [9]. Competitive Landscape - Allulose's approval is a significant event for the sugar substitute industry, marking a new phase of development. Companies with technological and production capacity reserves, such as Bailing Chuangyuan, Bailingbao, and COFCO Technology, are expected to have favorable market prospects [8][16]. - The competitive advantage of allulose includes its low caloric content, low glycemic index, and ability to participate in the Maillard reaction, which enhances its application in baked goods [12][16]. Financial Projections - Bailing Chuangyuan's profit growth exceeded expectations at 52% in Q1 2025, with projected annual revenue and profit growth rates of over 35% and 43% respectively [3][19]. - COFCO Technology's stock price is worth monitoring, with a target price of 6.8 yuan, reflecting a projected year-on-year growth of approximately 300% [1][8]. Conclusion - The approval of allulose as a new food ingredient is expected to stimulate capacity release and expand market opportunities for companies with established production capabilities. The overall outlook for the sugar substitute industry remains positive, with significant growth potential in various food applications [1][8][16].

Investment Rating - The industry investment rating is "Outperform the Market" (maintained rating) [6] Core Viewpoints - The approval of D-Allulose as a new food ingredient in China marks its official application license, indicating significant market potential as a low-calorie sweetener with health benefits [1][2] - The global D-Allulose market is projected to grow at a CAGR of 33.26% from 2019 to 2023, with an expected market size of USD 545 million by 2030 [1] - Companies with relevant production capacity and technology are expected to benefit from the industry boom, with key recommendations including Bailong Chuangyuan, Baolingbao, and COFCO Technology [3] Summary by Sections Section 1: Industry Overview - D-Allulose is a natural low-calorie sweetener found in various plants, with a sweetness level of 70% compared to sucrose and only one-tenth of its calories [1] - The substance has been recognized for its health benefits, including vascular health and blood sugar regulation [1] Section 2: Production and Companies - COFCO Technology is the first and only company in China to produce D-Allulose using enzyme technology, having developed a proprietary enzyme for its production [2] - Bailong Chuangyuan has achieved over RMB 156 million in revenue from D-Allulose, with plans for significant capacity expansion in Thailand [3] - Baolingbao has been involved in D-Allulose research for nearly a decade and is expanding its production capacity to 30,000 tons by 2026 [3] Section 3: Investment Recommendations - The report recommends buying shares of Bailong Chuangyuan, Baolingbao, and COFCO Technology due to their established market positions and expansion plans [3][5]

Group 1: Industry Overview - The sugar substitute industry is experiencing positive developments, with the sugar substitute concept stocks showing strong performance, particularly in the A-share market, where the market capitalization of Baolingbao approaches 5 billion yuan [1] - The market size of sugar substitutes in China reached 1.8 billion yuan in 2023, with projections to exceed 3.3 billion yuan by 2028, driven by increasing consumer demand for healthier diets and reduced sugar intake [4] Group 2: Company Developments - Baolingbao, a key player in the sugar substitute market, reported a net profit of 50 million yuan in Q1, representing a year-on-year increase of 117.35% [1] - The company is expanding its production capacity for D-alulose, with plans to start a 20,000-ton annual production project by March 2025, aiming for a total capacity of approximately 30,000 tons by 2026 [2] - Other companies like Bailing Chuangyuan and Sanyuan Biological are also increasing their production capacities for D-alulose, with Bailing Chuangyuan's project set to commence in May 2024 [2][3] Group 3: Market Trends - D-alulose, a rare sugar with 70% of the sweetness of sucrose but only 0.3% of its calories, is gaining traction in the market due to its high sweetness, low calories, and safety [5] - The global market for D-alulose was valued at approximately 237 million USD in 2023, with a compound annual growth rate (CAGR) of 7.7%, expected to reach 423 million USD by 2030 [5] Group 4: Stock Performance - Sugar substitute concept stocks have shown strong performance this year, with an average increase of 20.51%, significantly outperforming the Shanghai Composite Index [6] - Several sugar substitute stocks, including Baolingbao and Bailing Chuangyuan, have seen cumulative increases exceeding 40% [6] - As of July 2, 2023, six sugar substitute concept stocks reported net profits exceeding 100 million yuan in Q1, indicating robust financial performance [6]